Skip to main content
Englewood Lab, Inc. logo

Englewood Lab, Inc. — Investor Relations & Filings

Ticker · 950140 ISIN · KR8840110108 KO Manufacturing
Open in API
Filings indexed 211 across all filing types
Latest filing 2020-03-12 Proxy Solicitation & In…
Country US United States of America
Listing KO 950140

About Englewood Lab, Inc.

http://englewoodlab.com

Englewood Lab, Inc. is a contract manufacturer specializing in the research, development, and production of cosmetic products. The company focuses primarily on skincare and Over-the-Counter (OTC) formulations, offering a diverse portfolio that includes creams, serums, cleansers, masks, and hybrid beauty products. It provides comprehensive services to a global client base, encompassing formulation, stability testing, package compatibility, and full-scale manufacturing. The company's approach is centered on innovation through scientific research, adherence to stringent global quality control standards, and fostering trusted partnerships via transparent communication and client collaboration throughout the development process.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Englewood Lab, Inc. It contains the agenda for the 5th Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, cash flow) and management's discussion of business operations as part of the meeting materials. This is a standard proxy solicitation document sent to shareholders to inform them of the meeting and provide necessary information for voting.
2020-03-12 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the Korean regulatory authority (KRX). It provides the auditor's opinion (unqualified/proper), key financial data (assets, liabilities, equity, profit/loss) for both consolidated and separate financial statements, and details regarding the auditor. While it contains financial data, it is a specific regulatory filing required upon the completion of an audit, distinct from a full 10-K annual report or a simple earnings release. Given the specific nature of audit report filings in the Korean market, it falls under the Audit Report category. FY 2019
2020-03-02 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the resignation of an outside director (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This type of disclosure specifically pertains to changes in the composition of the board of directors, which falls under the 'Board/Management Information' category.
2020-02-28 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Englewood Lab) announcing a significant change in financial performance (revenue or profit/loss structure exceeding 30%). This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report material financial changes before the final audit report is finalized. It provides key financial highlights and reasons for the change, fitting the definition of an Earnings Release (ER) as it serves as an initial announcement of financial results.
2020-02-20 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Preliminary Earnings Release' (영업(잠정)실적) from Englewood Lab. It provides a summary table of key financial metrics (revenue, operating profit, net income) for the 4th quarter of 2019 compared to previous periods. It explicitly states that these are preliminary figures (잠정치) and have not yet been audited. This fits the definition of an Earnings Release (ER), which is the initial announcement of periodic financial results. Q4 2019
2020-01-22 Korean
기타경영사항(자율공시)(제5기 정기주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고)
AGM Information Classification · 95% confidence The document is a regulatory announcement regarding the setting of a record date for the 5th Annual General Meeting (AGM) to determine shareholder voting rights. It is a formal notice issued by the company (Englewood Lab) to the market regarding administrative procedures for an upcoming meeting. Since it does not contain the full proxy materials or the meeting presentation itself, but rather serves as a regulatory notice of a corporate event, it falls under the general regulatory filing category.
2019-12-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.